Holt Capital Advisors, L.L.C. Dba Holt Capital Partners, L.P. Merck & Co., Inc. Transaction History
Holt Capital Advisors, L.L.C. Dba Holt Capital Partners, L.P.
- $653 Million
- Q3 2024
A detailed history of Holt Capital Advisors, L.L.C. Dba Holt Capital Partners, L.P. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Holt Capital Advisors, L.L.C. Dba Holt Capital Partners, L.P. holds 5,168 shares of MRK stock, worth $497,730. This represents 0.09% of its overall portfolio holdings.
Number of Shares
5,168
Previous 4,250
21.6%
Holding current value
$497,730
Previous $526,000
11.41%
% of portfolio
0.09%
Previous 0.11%
Shares
9 transactions
Others Institutions Holding MRK
# of Institutions
3,821Shares Held
1.88BCall Options Held
15.6MPut Options Held
13.7M-
Vanguard Group Inc Valley Forge, PA250MShares$24.1 Billion0.52% of portfolio
-
Black Rock Inc. New York, NY207MShares$20 Billion0.59% of portfolio
-
State Street Corp Boston, MA119MShares$11.5 Billion0.56% of portfolio
-
Wellington Management Group LLP Boston, MA75.8MShares$7.3 Billion1.55% of portfolio
-
Geode Capital Management, LLC Boston, MA59.2MShares$5.7 Billion0.55% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $244B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...